ArticleAsian Pacific journal of cancer prevention : APJCP2019

Sequential Administration of EGFR-TKI and Pemetrexed Achieved a Long Duration of Response in Advanced NSCLC Patients with EGFR-mutant Tumours.

Chen Yue-Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.